Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Davignon

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Frontiers of Radiation Therapy and Oncology|January 1, 1980
Delta-9-tetrahydrocannabinol: comments on antiemetic trialsJ P Davignon
Cancer Chemotherapy Reports. Part 3|May 1, 1972
Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: dose formulationJ P Davignon
The New England Journal of Medicine|December 15, 1977
Contaminated laetrile: a health hazardJ P Davignon
Revue Francaise Des Prothesistes Dentaires|September 1, 1984
[The tradition of gold]J P Davignon
Revue Francaise Des Prothesistes Dentaires|July 1, 1984
[Platinum: the little unloved silver]J P Davignon
Revue Francaise Des Prothesistes Dentaires|April 1, 1985
[Medicinal plants of long ago specific to dentistry]M Yon, J P Davignon
Journal of Pharmaceutical Sciences|May 1, 1978
Dissolution and absorption of the antineoplastic agent ellipticineA Rahman, J C Cradock, J P Davignon
Journal of Clinical Pharmacology|August 1, 1981
Mechanism for national distribution of delta 9-tetrahydrocannabinol (NSC-134454)D Abraham, K R Pina, J P Davignon
Journal of Chromatography|February 6, 1981
Determination of delta 9-tetrahydrocannabinol in pharmaceutical vehicles by high-performance liquid chromatographyK P Flora, J C Cradock, J P Davignon
Bulletin of the Parenteral Drug Association|September 1, 1977
Intrathecal injections--a review of pharmaceutical factorsJ C Cradock, L M Kleinman, J P Davignon
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers of Radiation Therapy and Oncology|January 1, 1980
Delta-9-tetrahydrocannabinol: comments on antiemetic trialsJ P Davignon
Cancer Chemotherapy Reports. Part 3|May 1, 1972
Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: dose formulationJ P Davignon
The New England Journal of Medicine|December 15, 1977
Contaminated laetrile: a health hazardJ P Davignon
Revue Francaise Des Prothesistes Dentaires|September 1, 1984
[The tradition of gold]J P Davignon
Revue Francaise Des Prothesistes Dentaires|July 1, 1984
[Platinum: the little unloved silver]J P Davignon
Revue Francaise Des Prothesistes Dentaires|April 1, 1985
[Medicinal plants of long ago specific to dentistry]M Yon, J P Davignon
Journal of Pharmaceutical Sciences|May 1, 1978
Dissolution and absorption of the antineoplastic agent ellipticineA Rahman, J C Cradock, J P Davignon
Journal of Clinical Pharmacology|August 1, 1981
Mechanism for national distribution of delta 9-tetrahydrocannabinol (NSC-134454)D Abraham, K R Pina, J P Davignon
Journal of Chromatography|February 6, 1981
Determination of delta 9-tetrahydrocannabinol in pharmaceutical vehicles by high-performance liquid chromatographyK P Flora, J C Cradock, J P Davignon
Bulletin of the Parenteral Drug Association|September 1, 1977
Intrathecal injections--a review of pharmaceutical factorsJ C Cradock, L M Kleinman, J P Davignon
Pageof 2